We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$940M
AUM Growth
-$233M
Cap. Flow
-$192M
Cap. Flow %
-20.48%
Top 10 Hldgs %
46.78%
Holding
113
New
30
Increased
18
Reduced
25
Closed
32

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$26.6M
2
ELV icon
Elevance Health
ELV
+$26.1M
3
MLYS icon
Mineralys Therapeutics
MLYS
+$16.4M
4
BAX icon
Baxter International
BAX
+$16.3M
5
RDNT icon
RadNet
RDNT
+$14.8M

Top Sells

Rank Stock Value
1
CNC icon
Centene
CNC
+$30.3M
2
CAH icon
Cardinal Health
CAH
+$29.6M
3
LLY icon
Eli Lilly
LLY
+$29.3M
4
ISRG icon
Intuitive Surgical
ISRG
+$20.9M
5
MRK icon
Merck
MRK
+$19.9M

Sector Composition

Rank Sector Weight
1 Healthcare 96.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RZLT icon
76
Rezolute
RZLT
$456M
$1.45M 0.15%
500,000
– –
CABA icon
77
Cabaletta Bio
CABA
$458M
$1.18M 0.13%
850,000
+350,000
+70% +$746K
TENX icon
78
Tenax Therapeutics
TENX
$60.3M
$1.09M 0.12%
+167,000
New +$1.07M
ANRO icon
79
Alto Neuroscience
ANRO
$1.14B
$864K 0.09%
400,000
+100,000
+33% +$358K
PTN
80
Palatin Technologies
PTN
$14.5M
$583K 0.06%
+20,000
New +$931K
FATE icon
81
Fate Therapeutics
FATE
$325M
$553K 0.06%
700,000
+100,000
+17% +$123K
ACLX
82
DELISTED
Arcellx
ACLX
– –
-100,000
Closed -$6.77M
APLS
83
DELISTED
Apellis Pharmaceuticals
APLS
– –
-420,000
Closed -$13.4M
AZN icon
84
AstraZeneca
AZN
$244B
– –
-112,500
Closed -$14.7M
BRKR icon
85
Bruker
BRKR
$8.77B
– –
-100,000
Closed -$5.86M
CAH icon
86
Cardinal Health
CAH
$55.1B
– –
-250,000
Closed -$29.6M
CMPS
87
Compass Pathways
CMPS
$1.93B
– –
-200,000
Closed -$756K
CNC icon
88
Centene
CNC
$33.1B
– –
-500,000
Closed -$30.3M
COO icon
89
Cooper Companies
COO
$14.9B
– –
-100,000
Closed -$9.19M
DGX icon
90
Quest Diagnostics
DGX
$26.3B
– –
-130,000
Closed -$19.6M
EXAS
91
DELISTED
Exact Sciences
EXAS
– –
-150,000
Closed -$8.43M
HUM icon
92
Humana
HUM
$46.2B
– –
-40,000
Closed -$10.1M
ILMN icon
93
Illumina
ILMN
$28.9B
– –
-40,000
Closed -$5.35M
INSM icon
94
CALL
Insmed
INSM
$29.3B
– –
-500,000
Closed -$34.5M
ISRG icon
95
Intuitive Surgical
ISRG
$143B
– –
-40,000
Closed -$20.9M
JANX icon
96
Janux Therapeutics
JANX
$1.02B
– –
-200,000
Closed -$10.7M
KROS icon
97
Keros Therapeutics
KROS
$212M
– –
-450,000
Closed -$7.12M
LLY icon
98
Eli Lilly
LLY
$1.09T
– –
-38,000
Closed -$29.3M
MRK icon
99
Merck
MRK
$330B
– –
-200,000
Closed -$19.9M
PLRX icon
100
Pliant Therapeutics
PLRX
$65M
– –
-300,000
Closed -$3.95M
1 2 3
4
5

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return

Integral Health Asset Management's Q1 2025 Portfolio in Review

As of Q1 2025, Integral Health Asset Management held 113 positions worth $940M, down 20% from $1.17B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Integral Health Asset Management withdrew a net $192M in Q1 2025, closing 32 positions and reducing 25 holdings. Its most notable exit was Centene, an estimated $30.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 96% a quarter earlier.

Against the trend, Integral Health Asset Management opened a new position in Novartis worth $27.9M.

  • Integral Health Asset Management's largest Q1 2025 buy was Novartis: 250,000 shares worth $27.9M.
  • Integral Health Asset Management added most to Mineralys Therapeutics in Q1 2025, an estimated $16.4M increase.
  • Integral Health Asset Management's biggest Q1 2025 reduction was CVS Health, cutting an estimated $18M.
  • Integral Health Asset Management fully exited Centene in Q1 2025, selling an estimated $30.3M.
  • Integral Health Asset Management's ten largest holdings make up 47% of its $940M portfolio in Q1 2025.
  • Integral Health Asset Management opened 30 new positions and closed 32 in Q1 2025.
  • Integral Health Asset Management's portfolio value fell 20% quarter-over-quarter to $940M.

Based on Integral Health Asset Management's 13F filing for Q1 2025, filed 15 May 2025.